1. Home
  2. CGEM vs MEG Comparison

CGEM vs MEG Comparison

Compare CGEM & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • MEG
  • Stock Information
  • Founded
  • CGEM 2016
  • MEG 2012
  • Country
  • CGEM United States
  • MEG United States
  • Employees
  • CGEM N/A
  • MEG N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • MEG Professional Services
  • Sector
  • CGEM Health Care
  • MEG Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • MEG Nasdaq
  • Market Cap
  • CGEM 506.1M
  • MEG 580.0M
  • IPO Year
  • CGEM 2021
  • MEG 2020
  • Fundamental
  • Price
  • CGEM $7.50
  • MEG $13.60
  • Analyst Decision
  • CGEM Strong Buy
  • MEG Buy
  • Analyst Count
  • CGEM 8
  • MEG 5
  • Target Price
  • CGEM $32.86
  • MEG $33.60
  • AVG Volume (30 Days)
  • CGEM 398.2K
  • MEG 562.7K
  • Earning Date
  • CGEM 05-14-2025
  • MEG 05-06-2025
  • Dividend Yield
  • CGEM N/A
  • MEG N/A
  • EPS Growth
  • CGEM N/A
  • MEG N/A
  • EPS
  • CGEM N/A
  • MEG N/A
  • Revenue
  • CGEM N/A
  • MEG $696,395,000.00
  • Revenue This Year
  • CGEM N/A
  • MEG $9.68
  • Revenue Next Year
  • CGEM $278.37
  • MEG $7.50
  • P/E Ratio
  • CGEM N/A
  • MEG N/A
  • Revenue Growth
  • CGEM N/A
  • MEG 11.56
  • 52 Week Low
  • CGEM $7.27
  • MEG $13.40
  • 52 Week High
  • CGEM $30.19
  • MEG $49.97
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 31.16
  • MEG 32.07
  • Support Level
  • CGEM $8.01
  • MEG $14.28
  • Resistance Level
  • CGEM $9.16
  • MEG $15.79
  • Average True Range (ATR)
  • CGEM 0.45
  • MEG 1.00
  • MACD
  • CGEM -0.06
  • MEG -0.12
  • Stochastic Oscillator
  • CGEM 10.91
  • MEG 4.81

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: